Increased expression of mTOR in diabetes is known to result in insulin resistance, which has brought about the creation of mTOR inhibitors such as rapamycin for diabetic treatment (Blagosklonny, 2019; Um et al., 2006). The gene discussed is MTOR; the disease is diabetes mellitus.